We are pleased to announce that the 5th pilot rapid assessment of WP5 JA2 Strand B on “Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation” is available.
Mitral regurgitation (MR) is a common heart valve disorder. There are two types of chronic MR: primary (degenerative) MR and secondary (functional) MR. Three different transcatheter mitral valve repair devices and procedures are approved in Europe for the treatment of adult patients with chronic MR: MitraClip® System (Abbott Vascular International) for leaflet repair, CARILLON® Mitral Contour System® (Cardiac Dimensions, Inc.) for annulus repair, and NeoChord DS1000 (NeoChord, Inc.) for chordal repair.
This assessment addresses the research question whether the use of such technologies is more effective and/or safer than their comparators, which were chosen based on CE mark indications, recommendations in clinical guidelines for the treatment of MR and EUnetHTA guidelines.
wp5-sb-15_final_project_plan
wp5-sb-15_transcatheter_implantable_dvices_for_mitral_valve_repair
wp5-sb-15_comments_tables
